Synapticure, a telehealth company focused on people living with neurodegenerative diseases and their caregivers, announced it has partnered with Pearl Health, a technology company focused on supporting physicians in value-based care, to provide personalized support to Medicare patients with dementia.
The collaboration aims to benefit people living with dementia and their families through the CMS GUIDE (Guiding an Improved Dementia Experience) program.
The CMS GUIDE program, which launched in July, offers online consultations with Synapticure neurologists and approximately 80 hours of respite care services from skilled providers to ease the burden on caregivers.
The partnership will enable Pearl Health primary care providers across the U.S. to refer their Medicare patients to Synapticure as part of a proactive, value-based approach strategy.
“Synapticure's partnership with Pearl Health through the GUIDE program democratizes access to quality dementia care, including expert neurologists, behavioral medicine and comprehensive caregiver support within one week of a consultation,” Sandra Abrebaya, caregiver and CEO of Synapticure, said in a statement. “This approach ensures patients receive the highest quality care in their own home.”
Dr. Cameron Berg, executive vice president of clinical strategy at Pearl Health, explained that the partnership with Snapticure will further empower the company's primary care providers to deliver the right care at the right time.
“Both organizations share a commitment to improving quality of life and the highest standards of clinical, technical and operational competence,” Berg said.
Larger trends
Chicago-based Synapticure was founded in 2022 with $6 million in seed funding in a round led by Google Ventures (GV).
In April, Synapticure partnered with the ALS Association to offer Synapticure's telehealth platform as a supplement to in-person care at ALS Certified Centers of Excellence and Accredited Treatment Centers.
In 2023, Pearl Health partnered with Walgreens to work with primary care providers to expand value-based care options. Additionally, Pearl expects to raise $55 million in Series B funding and receive a $20 million credit facility separate from the equity raise.
Andreessen Horowitz and Viking Global Investors led the 2023 round, just two years after the company secured $18 million in Series A funding.
Pearl announced a number of partnerships this year, including a collaboration with Centene Corp.'s Medicare brand, WellCare, to work with primary care physicians to improve value-based care.
The company also announced strategic alliances with PraxisCare and Adaugeo Healthcare Solutions to provide access to value-based care services to patients of multiple Medicare Accountable Care Organizations (ACOs) and MDX Hawaii, a large physician network in Hawaii.
